OnKure Therapeutics (OKUR) Total Current Liabilities (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Total Current Liabilities for 7 consecutive years, with $6.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities fell 12.56% year-over-year to $6.6 million; the trailing twelve-month figure through Jun 2026 stood at $6.6 million (down 12.56% YoY), and the FY2025 full-year result was $5.9 million, down 43.77% from the prior year.
• Total Current Liabilities fell to $6.6 million in Q2 2026 per OKUR's latest filing, from $14.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $14.3 million in Q1 2026 and bottomed at $1.3 million in Q2 2024.
• Historically, Total Current Liabilities has averaged $8.1 million across 5 years, with a median of $7.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities plunged 90.19% in 2024, then surged 463.58% in 2025.
• Over 5 years, Total Current Liabilities stood at $7.1 million in 2022, then advanced by 2.26% to $7.3 million in 2023, then surged by 44.54% to $10.5 million in 2024, then plunged by 43.77% to $5.9 million in 2025, then climbed by 12.19% to $6.6 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $6.6 million, $14.3 million, and $5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.